|
Understanding mitochondrial fatty acid utilization requires more than measuring lipid abundance or mitochondrial activity. Recent studies highlight the need to determine where lipids are stored, how they are mobilized, whether fatty acids enter mitochondrial metabolism, and how these changes affect cellular function and survival.
|
|
Proximity proteomics reveals a mechanism of fatty acid transfer at lipid droplet-mitochondria-endoplasmic reticulum contact sites
(Bezawork-Geleta et al., Nature Communications, 2025)
Summary:
In this study, proximity labeling identified a three proteins complex at contact sites among lipid droplets, mitochondria, and endoplasmic reticulum. Loss or reduction of these proteins increased lipid droplets and neutral lipids, decreased oxidation and TCA cycle entry of lipid droplet derived fatty acids, and intensified lipid induced cellular stress, supporting a model linking fatty acid transfer with lipid balance.
Highlighted technique:
To define how lipid droplet derived fatty acids are transported and used, the authors mapped proteins near lipid droplet and mitochondrial contact sites, traced labeled fatty acids into oxidation products and TCA cycle metabolites, and measured oxygen consumption and mitochondrial mass to distinguish selective impairment of lipid use from general mitochondrial dysfunction.
Lipid droplet staining can be combined with, ATP to ADP ratio, mitochondrial membrane potential, and OCR measurements to complement analysis of lipid accumulation, fuel use, and mitochondrial function.
KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
(Thakur et al., Cancer Research, 2026)
Summary:
In this study, pancreatic cancer cells shifted from glucose and glutamine metabolism to lipid droplet derived fatty acid oxidation after KRAS pathway inhibition. Lipid tracing and functional interventions showed that lysosomal lipid breakdown supplied this fuel. This adaptation supported cell survival, while blocking fatty acid oxidation increased treatment responses in cells, organoids, and mouse tumors.
Highlighted technique:
To determine which fuel supported survival after pathway inhibition, the authors traced labeled glucose, glutamine, and fatty acids into energy producing pathways. They also followed labeled lipids stored in lipid droplets, measured oxygen consumption and cell survival, and altered lysosomal lipid breakdown and fatty acid oxidation.
Combining lipid droplet and lysosome staining with autophagic flux, OCR, ATP production, and cell viability measurements may provide complementary insight into metabolic adaptation and treatment response.
Which Step of Lipid-Derived Fuel Use Do You Need to Evaluate? (click to open/close)
| Research question |
Approach |
Are lipid stores changing?
Assess lipid droplet abundance and distribution as a starting point for distinguishing storage from utilization. |
Lipid droplet staining
Blue / Green / Red / Deep Red |
Are stored lipids being mobilized?
Examine lipid droplet–lysosome association to distinguish lysosomal involvement from changes in storage alone. |
Co-staining
Lipid droplet staining
Blue / Green / Red / Deep Red
Lysosome staining
Green / Deep Red |
Does lipid use affect cell function?
Measure respiration, energy status, and viability to link lipid handling with metabolic adaptation and survival. |
Measure OCR
Measure ATP/ADP ratio
Measure Cell Viability |
Application Note (click to open/close)
> Experimental Example: Hepatotoxicity test of drug-induced lipidosis using high-content imaging
|
Propranolol (a sympathetic β-receptor blocker) was added to a human hepatocellular carcinoma cell line (HepG2 cells), and changes in lipid droplets were observed under a fluorescence microscope. The accumulation of lipid droplets was analyzed by measuring the number, area, and fluorescence intensity of lipid droplets from the acquired microscopic images.


High Content Analysis (HCA) microscope system
(Nikon Corporation https://www.microscope.healthcare.nikon.com/)
For details of staining and analysis methods, please refer to "APPLICATION NOTE: Hepatotoxicity test of drug-induced lipidosis using high-content imaging" by Nikon Corporation.
|
|